Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension

Background. Blinded clinical trials have reported a modest and transient “start-up syndrome” with initiation of tenofovir-based pre-exposure prophylaxis (PrEP). We evaluate this phenomenon and its effect on adherence in an open-label PrEP study. Methods. In the iPrEx open-label extension (OLE) study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Glidden, David V., Amico, K. Rivet, Liu, Albert Y., Hosek, Sybil G., Anderson, Peter L., Buchbinder, Susan P., McMahan, Vanessa, Mayer, Kenneth H., David, Burns, Schechter, Mauro, Grinsztejn, Beatriz, Guanira, Juan, Grant, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
HIV/AIDS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826449/
https://ncbi.nlm.nih.gov/pubmed/26797207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados